Correlation Between Agios Pharm and Imunon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Imunon Inc, you can compare the effects of market volatilities on Agios Pharm and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Imunon.

Diversification Opportunities for Agios Pharm and Imunon

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Agios and Imunon is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of Agios Pharm i.e., Agios Pharm and Imunon go up and down completely randomly.

Pair Corralation between Agios Pharm and Imunon

Given the investment horizon of 90 days Agios Pharm is expected to generate 0.66 times more return on investment than Imunon. However, Agios Pharm is 1.53 times less risky than Imunon. It trades about 0.4 of its potential returns per unit of risk. Imunon Inc is currently generating about -0.06 per unit of risk. If you would invest  4,443  in Agios Pharm on September 1, 2024 and sell it today you would earn a total of  1,496  from holding Agios Pharm or generate 33.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Agios Pharm  vs.  Imunon Inc

 Performance 
       Timeline  
Agios Pharm 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.
Imunon Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Imunon Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Agios Pharm and Imunon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agios Pharm and Imunon

The main advantage of trading using opposite Agios Pharm and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.
The idea behind Agios Pharm and Imunon Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges